2025 Q4 -tulosraportti
31 päivää sitten
‧1 t 12 min
7,95 DKK/osake
Irtoamispäivä 27.3.
4,69%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 259 | - | - | ||
| 258 | - | - | ||
| 446 | - | - | ||
| 446 | - | - | ||
| 126 | - | - |
Ylin
255,25VWAP
Alin
246,2VaihtoMäärä
1 606,2 6 430 038
VWAP
Ylin
255,25Alin
246,2VaihtoMäärä
1 606,2 6 430 038
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·3 t sittenWell – it seems that I won't be hit by the upcoming wealth tax this time, thanks Novo😄
·2 t sittenCapycat-comment🫵 direktw inspiration from Zealand Pharma forum
·4 t sittenAre you increasing your position now that there's a dividend soon?·4 t sittenNot because there is a dividend soon but because there is great potential in the stock.·4 t sittenWell, yes, but if one could gain 5 percent extra, it wouldn't be a problem :)
4 t sitten4 t sittenAs I have said many times, Novo drugs are mostly useless. Here’s a link to a recent study highlighting what diabetes actually is and how you hence fix your type 2 diabetes without drugs. https://x.com/robertlufkinmd/status/2029961607216763060 Btw, most of this has been known for years, but the information has been suppressed. Investing in a lie doesn’t make sense in the long term, you know.
·1 t sittenDon't read that stuff from x. But it probably says something like if you cut out carbohydrates of a certain type, insulin sensitivity will return and one will therefore not have diagnosed type 2 diabetes. The problem is that many of those who have type 2 diabetes are more dependent on carbohydrates and other unhealthy food and drink than insulin. In addition, such a diet is very difficult and expensive to maintain and was only used in very few cases for those who could not receive insulin as treatment. GLP-1 has more positive sides than negative and will therefore be an exemplary product in its entirety for the near future. If one were to follow your motive, it would then be idiotic to buy shares anyway because it is something that shouldn't work but does for now. Sugar water, for example, is not really something one needs or medically desires, but people still drink it even with the knowledge of the health problems surrounding the products. Fakktard
·5 t sittenI agree that Zealand disappoints. But again today, we see a stock market with only one focus when it comes to obesity, GREATEST weight loss in percentage. Nothing else is evaluated than that, and prices are deducted 20-40 percent of the value in an instant. That is indeed very unnuanced, given what truly matters for future sales success. customers/patients seem to demand completely different benefits and properties than just losing as much weight as possible. Why does the market react so ''primitively'' ?? Isn't it precisely here that the market can be completely wrong?
·2 t sittenHow could you ever make good purchases if the market was economically rational? You must look inwards. When you buy a stock cheaply, it's an upturn. When you already have it and it falls without economic rationale, it's a downturn. Know yourself and life will become an entertaining party.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
31 päivää sitten
‧1 t 12 min
7,95 DKK/osake
Irtoamispäivä 27.3.
4,69%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenWell – it seems that I won't be hit by the upcoming wealth tax this time, thanks Novo😄·2 t sittenCapycat-comment🫵 direktw inspiration from Zealand Pharma forum
- ·4 t sittenAre you increasing your position now that there's a dividend soon?·4 t sittenNot because there is a dividend soon but because there is great potential in the stock.·4 t sittenWell, yes, but if one could gain 5 percent extra, it wouldn't be a problem :)
- 4 t sitten4 t sittenAs I have said many times, Novo drugs are mostly useless. Here’s a link to a recent study highlighting what diabetes actually is and how you hence fix your type 2 diabetes without drugs. https://x.com/robertlufkinmd/status/2029961607216763060 Btw, most of this has been known for years, but the information has been suppressed. Investing in a lie doesn’t make sense in the long term, you know.·1 t sittenDon't read that stuff from x. But it probably says something like if you cut out carbohydrates of a certain type, insulin sensitivity will return and one will therefore not have diagnosed type 2 diabetes. The problem is that many of those who have type 2 diabetes are more dependent on carbohydrates and other unhealthy food and drink than insulin. In addition, such a diet is very difficult and expensive to maintain and was only used in very few cases for those who could not receive insulin as treatment. GLP-1 has more positive sides than negative and will therefore be an exemplary product in its entirety for the near future. If one were to follow your motive, it would then be idiotic to buy shares anyway because it is something that shouldn't work but does for now. Sugar water, for example, is not really something one needs or medically desires, but people still drink it even with the knowledge of the health problems surrounding the products. Fakktard
- ·5 t sittenI agree that Zealand disappoints. But again today, we see a stock market with only one focus when it comes to obesity, GREATEST weight loss in percentage. Nothing else is evaluated than that, and prices are deducted 20-40 percent of the value in an instant. That is indeed very unnuanced, given what truly matters for future sales success. customers/patients seem to demand completely different benefits and properties than just losing as much weight as possible. Why does the market react so ''primitively'' ?? Isn't it precisely here that the market can be completely wrong?·2 t sittenHow could you ever make good purchases if the market was economically rational? You must look inwards. When you buy a stock cheaply, it's an upturn. When you already have it and it falls without economic rationale, it's a downturn. Know yourself and life will become an entertaining party.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 259 | - | - | ||
| 258 | - | - | ||
| 446 | - | - | ||
| 446 | - | - | ||
| 126 | - | - |
Ylin
255,25VWAP
Alin
246,2VaihtoMäärä
1 606,2 6 430 038
VWAP
Ylin
255,25Alin
246,2VaihtoMäärä
1 606,2 6 430 038
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 |
2025 Q4 -tulosraportti
31 päivää sitten
‧1 t 12 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 | ||
2025 Q2 -tulosraportti 6.8.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 |
7,95 DKK/osake
Irtoamispäivä 27.3.
4,69%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenWell – it seems that I won't be hit by the upcoming wealth tax this time, thanks Novo😄·2 t sittenCapycat-comment🫵 direktw inspiration from Zealand Pharma forum
- ·4 t sittenAre you increasing your position now that there's a dividend soon?·4 t sittenNot because there is a dividend soon but because there is great potential in the stock.·4 t sittenWell, yes, but if one could gain 5 percent extra, it wouldn't be a problem :)
- 4 t sitten4 t sittenAs I have said many times, Novo drugs are mostly useless. Here’s a link to a recent study highlighting what diabetes actually is and how you hence fix your type 2 diabetes without drugs. https://x.com/robertlufkinmd/status/2029961607216763060 Btw, most of this has been known for years, but the information has been suppressed. Investing in a lie doesn’t make sense in the long term, you know.·1 t sittenDon't read that stuff from x. But it probably says something like if you cut out carbohydrates of a certain type, insulin sensitivity will return and one will therefore not have diagnosed type 2 diabetes. The problem is that many of those who have type 2 diabetes are more dependent on carbohydrates and other unhealthy food and drink than insulin. In addition, such a diet is very difficult and expensive to maintain and was only used in very few cases for those who could not receive insulin as treatment. GLP-1 has more positive sides than negative and will therefore be an exemplary product in its entirety for the near future. If one were to follow your motive, it would then be idiotic to buy shares anyway because it is something that shouldn't work but does for now. Sugar water, for example, is not really something one needs or medically desires, but people still drink it even with the knowledge of the health problems surrounding the products. Fakktard
- ·5 t sittenI agree that Zealand disappoints. But again today, we see a stock market with only one focus when it comes to obesity, GREATEST weight loss in percentage. Nothing else is evaluated than that, and prices are deducted 20-40 percent of the value in an instant. That is indeed very unnuanced, given what truly matters for future sales success. customers/patients seem to demand completely different benefits and properties than just losing as much weight as possible. Why does the market react so ''primitively'' ?? Isn't it precisely here that the market can be completely wrong?·2 t sittenHow could you ever make good purchases if the market was economically rational? You must look inwards. When you buy a stock cheaply, it's an upturn. When you already have it and it falls without economic rationale, it's a downturn. Know yourself and life will become an entertaining party.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 259 | - | - | ||
| 258 | - | - | ||
| 446 | - | - | ||
| 446 | - | - | ||
| 126 | - | - |
Ylin
255,25VWAP
Alin
246,2VaihtoMäärä
1 606,2 6 430 038
VWAP
Ylin
255,25Alin
246,2VaihtoMäärä
1 606,2 6 430 038
Välittäjätilasto
Dataa ei löytynyt